Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium
Global Research on interventional cardiology and peripheral vascular device
market provides an in-depth analysis of segments and sub-segments in the global
as well as regional interventional cardiology and peripheral vascular device
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional interventional cardiology and peripheral
vascular device market over the short term as well as long term. The report is
a comprehensive presentation of trends, forecast and dollar values of global
interventional cardiology and peripheral vascular device market. According to
the report, the global interventional cardiology and peripheral vascular device
market is projected to grow at a healthy CAGR over the forecast period of
2019-2025.
Interventional cardiology deals with
catheter-based technologies for the treatment of structural heart diseases and
the insertion of a device into the peripheral artery or vein. Interventional
devices are also used to treat peripheral vascular disorders by devices such as
balloons, catheters, guidewires, stents, and filters. In August 2019, Merit
Medical Systems Inc Company has launched a Prelude Sync Evo radial compression
device. Prelude Sync Evo radial compression device has been designed for the
patient's comfort, safety and also provide operators improved clarity. The
Prelude Sync Evo is a sterile, single-use, disposable device used to assist in
gaining hemostasis of the arterial percutaneous access site following
catheterization procedures.
The increasing incidence of
cardiovascular disease is the factor driving the growth of the interventional
cardiology and peripheral vascular device market. Increasing geriatric
population is the factor propelling the growth of the interventional cardiology
and peripheral vascular device market. Technological advancements in cardiology
devices are the factor enhancing the interventional cardiology and peripheral
vascular device market. The development of minimally invasive procedures is the
factor boosting the interventional cardiology and peripheral vascular device
market. However, the availability of alternative devices remains one of the
major restraints to the interventional cardiology and peripheral vascular device
market. Moreover, the high cost of some devices and stringent approval
processes for the devices are the factors hampering the interventional
cardiology and peripheral vascular device market. Increasing healthcare
structure in the emerging markets offers favorable opportunities in the
interventional cardiology and peripheral vascular device market.
Geographically, North America is the
dominant region in the interventional cardiology and peripheral vascular device
market. Increasing healthcare expenditure in order to develop innovative
treatment and growing health awareness in people are factors driving the
interventional cardiology and peripheral vascular device market in North
America. Likewise, the increase in the number of percutaneous coronary
intervention (PCI) centers is driving the interventional cardiology and
peripheral vascular device market in North America. The Asia Pacific holds the
second largest market share in the interventional cardiology and peripheral
vascular device market due to increasing initiatives for the health betterment.
Europe is expected to grow at the highest CAGR in the forecast period.
The report on global interventional
cardiology and peripheral vascular device market covers segments such as
product type. On the basis of product type, the sub-markets include angioplasty
balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm
repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices,
hemodynamic flow alteration devices, and accessories.
The report provides profiles of the
companies in the market such as Siemens AG, AngioDynamics, Inc., Edwards
Lifesciences Corporation, Becton, Dickinson & Co., ABIOMED, Inc., Baxter
International Inc., Lepu Medical Technology (Beijing) Co. Ltd., 3M Company,
Smith & Nephew plc, and Biotronik SE & Co. KG.
The report provides deep insights into
the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of interventional cardiology and peripheral vascular device market.
Moreover, the study highlights current market trends and provides forecast from
2019-2025. We also have highlighted future trends in the market that will
affect the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share
of the leading players.
Please Choose One of them.